Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 275 entries
View as:

To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.

Phase: N/A Priority: Normal
NCT ID: NCT03161106 Org: User:
Start: 05/15/17 End: 10/01/18 Due: 10/01/19

Goal Directed Ammonia Lowering Therapy in Hyperammonemic ACLF Patients With no Overt HE to Reduce Major Adverse Liver Related Outcomes (GOAL Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06808009 Org: User:
Start: 02/05/25 End: 02/28/26 Due: 02/28/27

To Determine the Predictors of Reversibility for Acute-on-Chronic Liver Failure at 6-months.

Phase: N/A Priority: Normal
NCT ID: NCT06387160 Org: User:
Start: 04/20/24 End: 02/27/26 Due: 02/27/27

To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism

Phase: N/A Priority: Normal
NCT ID: NCT02265484 Org: User:
Start: 11/30/13 End: 01/31/15 Due: 01/31/16

Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04252794 Org: User:
Start: 08/08/19 End: 07/31/23 Due: 07/31/24

Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue

Phase: N/A Priority: Normal
NCT ID: NCT03120637 Org: User:
Start: 01/01/17 End: 01/10/18 Due: 01/10/19

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

Phase: N/A Priority: Normal
NCT ID: NCT01852630 Org: User:
Start: 12/31/12 End: 12/31/15 Due: 12/31/16

Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT04794946 Org: User:
Start: 03/19/21 End: 03/19/22 Due: 03/19/23

Early Versus Late Sustained Low Efficiency Dialysis in Critically Ill Cirrhotics With Septic Shock and Acute Kidney Injury

Phase: N/A Priority: Normal
NCT ID: NCT02937961 Org: User:
Start: 12/01/17 End: 03/01/19 Due: 03/01/20

Incidence and Spectrum of Acute Kidney Injury in Cirrhotics and Assessment of New Biomarkers as Early Predictors of Acute Kidney Injury

Phase: N/A Priority: Normal
NCT ID: NCT02016053 Org: User:
Start: 12/31/13 End: 05/31/15 Due: 05/31/16

Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.

Phase: N/A Priority: Normal
NCT ID: NCT05849220 Org: User:
Start: 05/15/23 End: 03/30/24 Due: 03/30/25

Spleen Stiffness as a Measure to Assess the REsponse to β Blocker Therapy (SPARE-B)

Phase: N/A Priority: Normal
NCT ID: NCT06050837 Org: User:
Start: 09/30/23 End: 08/31/24 Due: 08/31/25

Fecal Microbiota Therapy in Steroid Ineligible Alcoholic Hepatitis

Phase: N/A Priority: Normal
NCT ID: NCT05285592 Org: User:
Start: 04/01/22 End: 03/31/24 Due: 03/31/25

Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT01677871 Org: User:
Start: 09/30/12 End: 09/30/14 Due: 09/30/15

To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01649037 Org: User:
Start: 08/31/12 End: 06/30/15 Due: 06/30/16

Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT04433481 Org: User:
Start: 06/20/20 End: 05/31/22 Due: 05/31/23

Indirect Calorimeter Based Study in Patients With Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT03871894 Org: User:
Start: 03/12/19 End: 08/31/22 Due: 08/31/23

Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT02307409 Org: User:
Start: 06/01/14 End: 08/01/16 Due: 08/01/17

Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites

Phase: N/A Priority: Normal
NCT ID: NCT06091345 Org: User:
Start: 10/25/23 End: 02/27/25 Due: 02/27/26

Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

Phase: N/A Priority: Normal
NCT ID: NCT03702426 Org: User:
Start: 07/23/18 End: 07/31/19 Due: 07/31/20

To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.

Phase: N/A Priority: Normal
NCT ID: NCT05187715 Org: User:
Start: 02/26/22 End: 10/31/23 Due: 10/31/24

Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT05956197 Org: User:
Start: 07/25/23 End: 05/31/24 Due: 05/31/25

Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients

Phase: N/A Priority: Normal
NCT ID: NCT01260610 Org: User:
Start: 06/30/11 End: 06/30/11 Due: 06/30/12

Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.

Phase: N/A Priority: Normal
NCT ID: NCT04494451 Org: User:
Start: 09/15/21 End: 11/02/22 Due: 11/02/23

To Compare the Efficacy of Endoscopic Ultrasound Assisted Endoscopic Glue Injection and Conventional Endoscopic Injection Therapy for Prevention of Gastric Variceal Rebleed

Phase: N/A Priority: Normal
NCT ID: NCT01631890 Org: User:
Start: 06/30/12 End: 06/30/14 Due: 06/30/15